Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAGSYS is a global leader in item-level Radio Frequency Identification (RFID) solutions, providing critical infrastructure for the healthcare, pharmaceutical, and medical device industries. The company specializes in end-to-end inventory management systems that enable real-time tracking and authentication of pharmaceutical products and hospital assets. Their technology is specifically designed to enhance supply chain visibility, ensure product integrity, and improve patient safety by monitoring the movement of sensitive medical materials. In 2016, TAGSYS was acquired by HID Global, a subsidiary of ASSA ABLOY, to integrate its high-performance RFID hardware and software into a broader IoT identification portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAGSYS.